Wednesday, March 07, 2018 8:27:53 AM
they never provided with a revenue split between focalin-seroquel
I consider redicoulous that
IF they did pay in advance for new oxy studies they didn't inform shareholders
I consider outrageous that
in one of his rare interviews Odidi talks about many other project his running but nobody knows about it
These are examples of how the Odidis doesn't give a s....t about shareholders, and if there is the option to sacrifice them he wouldn't be so difficult for him to issue new shares and disintegrate our investments (becoming himself a minority interest in the co...but I am not sure he understands the risk...and honestly he would deserve it)
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM